Bisconti Fund for AI-Focused Research

June 28, 2022

Congratulations to CCB's Bisconti award winner!

Dr. Ming-Ru Wu, Assistant Professor of Cancer Immunology and Virology, Dana-Farber Cancer Institute and Harvard Medical School was selected as CCB’s winner of our Spring 2022 Bisconti award! 

Project Title:

Drugging the undruggable – machine-learning-based cancer immunotherapy design

Funding Period:

August 1st, 2022 –> July 31st, 2023

Future Award Opportunities

Our spring application cycle was the first of 5 total Bisconti awards that CCB will be sponsoring over the next few years. The next application cycle will be announced fall 2022.

At a Glance

  • $50,000 Funding opportunity to advance innovative Artificial Intelligence (AI) solutions for biomedical research and healthcare in collaboration with the Center for Computational Biomedicine (CCB).

Awardee:

Dr. Ming-Ru-Wu, Assistant Professor of Cancer Immunology and Virology, Dana-Farber Cancer Institute and Harvard Medical School

Project Title:

Drugging the undruggable – machine-learning-based cancer immunotherapy design

Funding Period:

August 1st, 2022 –> July 31st, 2023

Application details will be announced fall semester 2022.

Application details will be announced spring semester 2023.

Application details will be announced fall semester 2023.

Application details will be announced spring semester 2024.